Your session is about to expire
← Back to Search
Treatment for Drug Metabolism (POETRY Trial)
N/A
Waitlist Available
Led By Bill Massey, PhD
Research Sponsored by General Genetics Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days
Awards & highlights
Summary
The goal of the POETRY Registry is to determine whether data from Pharmacogenomic (PGx) Testing for elderly and disabled patients can help physicians manage patient medication regimens and assess if the testing has an effect on reducing adverse drug events, hospitalizations, and emergency department visits. The way an individual processes or metabolizes a drug is in part determined by their genes, and there is known to be genetic variation from one human to another. The study of the way in which genes affect an individual's response to drugs is known as "Pharmacogenomics."
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 90 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Occurrence of Meaningful Change in Drug Regimen
Secondary study objectives
Binary occurrence of whether, in the Investigator's opinion, the subject experienced clinical benefit from drug regimen changes made as a result of the PGx test
Find a Location
Who is running the clinical trial?
General Genetics CorporationLead Sponsor
SyntactxNETWORK
22 Previous Clinical Trials
867,439 Total Patients Enrolled
Bill Massey, PhDPrincipal InvestigatorNorthwestern University
Share this study with friends
Copy Link
Messenger